182 related articles for article (PubMed ID: 37818793)
1. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
[TBL] [Abstract][Full Text] [Related]
2. Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.
Cronjé HT; Liu X; Odden MC; Moseholm KF; Seshadri S; Satizabal CL; Lopez OL; Bis JC; Djoussé L; Fohner AE; Psaty BM; Tracy RP; Longstreth WT; Jensen MK; Mukamal KJ
Alzheimers Dement; 2023 Dec; 19(12):5672-5680. PubMed ID: 37392405
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
4. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
5. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
6. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
[TBL] [Abstract][Full Text] [Related]
7. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
9. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
11. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study.
Rübsamen N; Maceski A; Leppert D; Benkert P; Kuhle J; Wiendl H; Peters A; Karch A; Berger K
BMC Med; 2021 Feb; 19(1):38. PubMed ID: 33583409
[TBL] [Abstract][Full Text] [Related]
12. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
14. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
Lange RT; Lippa S; Brickell TA; Gill J; French LM
J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
[TBL] [Abstract][Full Text] [Related]
15. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
[TBL] [Abstract][Full Text] [Related]
18. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study.
van Gennip ACE; Satizabal CL; Tracy RP; Sigurdsson S; Gudnason V; Launer LJ; van Sloten TT
Geroscience; 2024 Feb; 46(1):505-516. PubMed ID: 37530894
[TBL] [Abstract][Full Text] [Related]
19. Blood biomarkers for dementia in Hispanic and non-Hispanic White adults.
Gonzales MM; Short MI; Satizabal CL; O' Bryant S; Tracy RP; Zare H; Seshadri S
Alzheimers Dement (N Y); 2021; 7(1):e12164. PubMed ID: 33860071
[TBL] [Abstract][Full Text] [Related]
20. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
